Name | Title | Contact Details |
---|---|---|
Sherry Kan |
Vice President, Marketing and Product Management | Profile |
Richard Chen |
Chief Medical Officer and Senior Vice President of R&D | Profile |
John Lyle |
VP Assay Development R&D | Profile |
Susan Moriconi |
Vice President of People and Chief Human Resources Officer | Profile |
Capstan Therapeutics is a biotechnology company dedicated to advancing in vivo cell reprogramming. The core platform technology comprises proprietary targeted lipid nanoparticles conjugated with a recombinant protein binder such as monoclonal antibodies (tLNPs) designed to deliver payloads, including mRNA or gene editing tools, that can reprogram specific cell types in vivo. The platform technology has the potential to generate transformative therapies with applications across a broad range of disease areas, including oncology, autoimmune disorders, fibrosis, and monogenic blood disorders.
Bactrin International is a Belgrade, MT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Mateon Therapeutics/Oncotelic is developing TGF-beta therapies and Apomorphine for Parkinson, ED, FSD. https://t.co/nReUVgPvhc. $OTLC
Akaza Research is a Waltham, MA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Gene Link Inc is a Hawthorne, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.